The Masked Singer South Africa is based on a reality show that first premiered in South Korea in 2015 and is now broadcast in over 50 countries worldwide. Each episode features a star-studded cast of celebrities, sports personalities, and entertainers who compete against each other by singing popular songs to a live audience while concealing their identities with elaborate costumes and masks. A celebrity panel of detectives evaluates each performance, trying to guess who might be behind the mask. The studio audience votes for their favourite performance, with one mystery singer eliminated and revealed each week.
Recognising the unique opportunity that partnering with this hit show presents, iNova Pharmaceuticals was thrilled to step up as a sponsor soon after the news was released by Primedia for Season 1 in 2023 and now for Season 2 in 2024.
“This is a perfect partnership, emphasising the need for a healthy mouth and throat when you need to perform at your best,” says Kym Hampton, Managing Director of iNova Pharmaceuticals, South Africa.
“This is the first sponsorship of this kind for Andolex®, which not only allows us to deepen our connection with current Andolex® consumers but also to reach a broader audience, driving the brand to new heights. We couldn’t be prouder to be associated with The Masked Singer South Africa, to be part of the hype and excitement, and the production of a show that will appeal to everyone,” said Kym.
Andolex® provides fast acting² relief of pain and inflammatory conditions of the mouth, throat, and gums with products found in homes around the country. The range includes Andolex® spray and oral rinse, Andolex® C spray, oral rinse, oral gel, and lozenges, as well as Andolex® pastilles, which help relieve symptoms of dry mouth and throat.
The Masked Singer South Africa currently airs on Saturdays on SABC 3 at 18:30, with repeats on SABC 1 at 21:00 on Thursdays, and again on SABC 3 on Fridays at 18:00. The show is a firm favourite among South African audiences.
For more information, go to www.andolex.co.za.
For full prescribing information, refer to the professional information as approved by the SAHPRA (South African Health
Products Regulatory Authority), available at www.inovapharma.co.za. For more information, speak to your healthcare provider. IN4900/24
References:
- IMS/TPM DATA MAT March 2024
- Valerio C, Di Loreto G, Salvatori E, Cattaneo A. Comparative evaluation of rapidity of action of benzydamine hydrochloride 0.3% oromucosal spray and benzydamine hydrochloride 3 mg lozenges in patients with acute sore throat: A phase IV randomized trial. Medicine (Baltimore). 2023;102(13):e33367. doi: 10.1097/MD.0000000000033367
